日本脑炎病毒NS4B通过向TLR3和TRIF来抑制干扰素β的产生
Quan Zeng1, Jiaqi Liu1, Zhaoyang Li1
1College of Veterinary Medicine, Henan Agricultural University, Zhengzhou 450002, Henan, China.
Veterinary microbiology
|August 19, 2023
概括
日本脑炎病毒非结构蛋白4B (NS4B) 通过向TLR3通路来阻碍身体的防御. 这种相互作用抑制了干扰素β的产生,有助于病毒复制.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 日本脑炎病毒 (JEV) 引起了人类和动物的健康问题,特别是在亚洲.
- 干扰素 (IFN) 对于宿主抗病毒防御至关重要,但病毒通常会逃避它.
- 弗拉维病毒非结构蛋白4B (NS4B) 与病毒复制和免疫逃避有关.
研究的目的:
- 研究JEV NS4B蛋白抑制宿主干扰素-β (IFN-β) 反应的机制.
- 为了确定特定的宿主目标和涉及JEV NS4B介导免疫逃避的途径.
主要方法:
- 双路西法酶记者测试用于评估IFN-β促进体活性.
- 实验包括用聚 (I:C) 刺激细胞激活TLR3通路.
- 同局部化和共免疫沉试验证实了蛋白质相互作用.
主要成果:
- JEV NS4B显著抑制了由TLR3刺激诱导的IFN-β促进体激活.
- 在TLR3路径中,NS4B抑制了IRF3及其上游分子的激活.
- 已经证明JEV NS4B与TLR3和TRIF相互作用,阻断下游信号传输.
结论:
- JEV NS4B通过向TLR3信号通路来抑制宿主抗病毒免疫力.
- NS4B与TLR3和TRIF的相互作用抑制了IFN-β的产生.
- 这项研究揭示了JEV NS4B.免疫逃避的新机制.
相关概念视频
01:29Immune Response Against Viral Pathogens
824
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
824
01:23RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K